Diagnostic Performance and Safety of <sup>18</sup> F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.-Reference-Cited by-同舟云学术

Diagnostic Performance and Safety of ¹⁸ F-rhPSMA-7.3 Positron Emission Tomography in Men With Suspected Prostate Cancer Recurrence: Results From a Phase 3, Prospective, Multicenter Study (SPOTLIGHT). Reply.

Published:2023-09 Issue:3 Volume:210 Page:411-412
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Jani Ashesh B.¹,Ravizzini Gregory C.²,Gartrell Benjamin A.³,Siegel Barry A.⁴,Twardowski Przemyslaw⁵,Saltzstein Daniel⁶,Fleming Mark T.⁷,Chau Albert⁸,Davis Phillip⁹,Chapin Brian F.¹⁰,Schuster David M.¹¹

Affiliation:

1. Department of Radiation Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia

2. Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas

3. Montefiore Medical Center, Bronx, New York

4. Division of Nuclear Medicine, Mallinckrodt Institute of Radiology and the Alvin J. Siteman Cancer Center, WashingtonUniversity School of Medicine, St Louis, Missouri

5. Saint John's Cancer Institute, Santa Monica, California

6. Urology San Antonio, San Antonio, Texas

7. Virginia Oncology Associates, US Oncology Research, Norfolk, Virginia

8. Blue Earth Diagnostics Ltd, Oxford, UK

9. Blue Earth Diagnostics, Inc, Monroe Township, New Jersey

10. Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, Texas

11. Division of Nuclear Medicine and Molecular Imaging, Department of Radiology and Imaging Sciences, Emory University, Atlanta, Georgia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Link

http://www.auajournals.org/doi/pdf/10.1097/JU.0000000000003598

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate specific membrane antigen (PSMA) avid nonprostatic benign and malignant disease: a pictorial review;Clinical Radiology;2024-09

2. Comparison of 18F-DCFPyL and 68Ga-PSMA-11 for 177Lu-PSMA-617 therapy patient selection;Frontiers in Oncology;2024-06-27

3. Distinguishing Physiological Ureter Uptake From an Involved Lymph Node in Staging Prostate-Specific Membrane Antigen (PSMA) Scans: Implications for Radiation Planning;Cureus;2024-06-25

4. Emerging Theranostics for Prostate Cancer and a Model of Prostate-specific Membrane Antigen Therapy;Radiology;2024-04-01

5. Salvage Therapy for Prostate Cancer: AUA/ASTRO/SUO Guideline Part I: Introduction and Treatment Decision-Making at the Time of Suspected Biochemical Recurrence after Radical Prostatectomy;Journal of Urology;2024-04